Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › teriparatide

teriparatide

4 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of teriparatide

39 trials tracked of teriparatide: 27 in phase 3 or 4 and 5 with published results. The most-cited published study has 579 citations.

39Trials tracked
27Phase 3 & 4
0Recruiting
5With published results
Phase distribution
Phase 4 15 Phase 3 12 Phase 2 9 Other / NA 3
  1. Phase 4 VERtebral Fracture Treatment Comparisons in Osteoporotic Women Completed · 579 cited
  2. Phase 3 An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women Completed · 463 cited
  3. Phase 4 Denosumab and Teriparatide Study (DATA-HD and DATA-EX) Completed · 69 cited
  4. Phase 3 Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women Completed · 47 cited
  5. Phase 4 Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial Completed · 37 cited
  6. Phase 4 A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture Completed
Show 33 more trials
  1. Phase 4 µMRI of Therapeutic Intervention in Postmenopausal Osteoporosis Completed
  2. Phase 4 Fracture (FX) Improvement With Teriparatide: FiX-IT Study Completed
  3. Phase 4 Use of Forteo (Teriparatide) in Posterolateral Lumbar Spine Fusion Completed
  4. Phase 4 Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration Completed
  5. Phase 4 Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis Completed
  6. Phase 4 Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI) Completed
  7. Phase 4 A Study of Teriparatide in Japanese Osteoporosis Patients Completed
  8. Phase 4 A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide Completed
  9. Phase 4 Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women Completed
  10. Phase 4 Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window? Completed
  11. Phase 4 Evaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal Women With Osteoporosis Completed
  12. Phase 3 A Study for Patients With Osteoporosis Completed
  13. Phase 3 Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy Completed
  14. Phase 3 Second Study of the Effect of Teriparatide on Hip Fracture Healing Completed
  15. Phase 3 Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis Completed
  16. Phase 3 Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With Glucocorticoid-Induced Osteoporosis Completed
  17. Phase 3 Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis Completed
  18. Phase 3 Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis Completed
  19. Phase 3 Effect of Teriparatide on Hip Fracture Healing Completed
  20. Phase 3 Phase 3 Clinical Trial of Teriparatide in Japan Completed
  21. Phase 3 Combination Risedronate - Parathyroid Hormone Trial in Male Osteoporosis Completed
  22. Phase 2 Dose Ranging Study - Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis Completed
  23. Phase 2 Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury Completed
  24. Phase 2 12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI) Completed
  25. Phase 2 Denosumab, Teriparatide or Both for the Treatment of Postmenopausal Osteoporosis Completed
  26. Phase 2 Forteo Trial on Idiopathic Osteoporosis in Premenopausal Women Completed
  27. Phase 2 The Role of Parathyroid Hormone (PTH) in Low Bone Mass in Anorexia Nervosa Completed
  28. Phase 2 Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density Completed
  29. Phase 2 Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis Completed
  30. Phase 2 Efficacy of Teriparatide in Diabetic Inactive Charcot Neuroarthropathy of Foot Completed
  31. N/A Renal Osteodystrophy: An Individual Management Approach Completed
  32. N/A Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women Completed
  33. N/A Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism Completed

Showing the 39 most-cited and recently-updated of 39 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Network meta-analysis compares osteoporosis drugs for bone density in men
Diabetes & Endocrinology Meta-analysis
Network meta-analysis compares osteoporosis drugs for bone density in men Men's Osteoporosis Drugs Work Better on Spines Than Hips
This network meta-analysis of 4,409 men with primary osteoporosis compared six medications. It found significant improvements in bone minera…
• Abaloparatide and teriparatide boost spine bone density most • Helps men with weak bones avoid fractures • Not yet proven to prevent actua…
Frontiers May 8, 2026
Romosozumab improves shear bone strength in postmenopausal women with osteoporosis in BCT substudies
Drug Pipeline RCT
Romosozumab improves shear bone strength in postmenopausal women with osteoporosis in BCT substudies Romosozumab May Help Spinal Fusion Surgery Last Longer
This retrospective secondary analysis of phase 2 and 3 randomized trial data evaluated romosozumab in postmenopausal women with low bone den…
A bone drug may make spinal fusion surgery more secure for women with weak bones, new virtual tests suggest.
May 1, 2026
Antiresorptive and Anabolic Agents Improve Bone Microarchitecture in Postmenopausal Women With Type 2 Diabetes: Pilot RCT
Diabetes & Endocrinology RCT
Antiresorptive and Anabolic Agents Improve Bone Microarchitecture in Postmenopausal Women With Type 2 Diabetes: Pilot RCT Diabetes Weakens Bones: One Drug Builds Them Back
This pilot randomized controlled trial evaluated antiresorptive and anabolic agents in 129 postmenopausal women with Type 2 Diabetes.
Building new bone tissue with a specific daily shot works better than just protecting existing bone for women with diabetes.
Apr 22, 2026
In male osteoporosis, anabolic therapies improved lumbar spine and hip BMD more than antiresorptives at 12 months
Diabetes & Endocrinology Meta-analysis
In male osteoporosis, anabolic therapies improved lumbar spine and hip BMD more than antiresorptives at 12 months Men Get Osteoporosis Too — and Now We Know Which Drugs Win
This Bayesian network meta-analysis evaluated antiresorptive and anabolic pharmacological interventions in men with osteoporosis.
A new analysis of 18 clinical trials finds that bone-building drugs may outperform bone-preserving drugs for men with osteoporosis, especial…
Frontiers Apr 10, 2026